Apixaban and Valdecoxib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Valdecoxib
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Apixaban (Eliquis) is a blood thinner, and valdecoxib is an anti-inflammatory pain reliever (an NSAID-type drug). When you take them together, they can each affect your body's ability to form clots. Put together, that means a higher chance of bleeding than either one alone.
Signs to watch for include unusual bruising, nosebleeds, pink or red urine, black or bloody stools, or bleeding that won't stop. This is a caution, not a reason to panic, and your care team can manage it. Please don't stop either medicine on your own. Instead, talk with your pharmacist or doctor so they can keep an eye on you and make sure this combination is right for you.
Effect: Additive pharmacodynamic interaction increasing bleeding risk. Both agents impair hemostasis, apixaban via direct factor Xa inhibition and valdecoxib (a COX-2 selective NSAID) via effects on platelet/GI mucosa, so combined use raises bleeding risk versus monotherapy.
- Direction: Increased bleeding risk (PD additive, not a PK/enzyme interaction).
- Evidence: Theoretical; severity rated major.
- Onset: Unspecified; heightened vigilance early after initiating the NSAID.
- Neuraxial caution: Elevated risk of epidural/spinal hematoma with neuraxial anesthesia or spinal puncture.
Management: If coadministration is required, monitor anticoagulant therapy and observe for bleeding, particularly in the first days. Individualize therapy and consider GI protection or alternative analgesics.
What happens
Increased risk of bleeding
Interaction Deep Dive
Using an anticoagulant together with an NSAID can raise the likelihood of significant bleeding compared with taking either agent by itself1, and it can also elevate the chance of epidural or spinal hematomas capable of causing long-lasting or permanent paralysis in patients undergoing neuraxial anesthesia or spinal puncture 23. If the two must be given together, keep track of anticoagulant therapy and watch the patient for signs of bleeding, especially in the initial few days following the start of parecoxib therapy 1.
Why it happens (mechanism)
Additive effect on hemostasis
How to manage this interaction
If your care team has you on both, keep taking them as prescribed unless they tell you otherwise. The main goal here is closer monitoring and awareness.
- Your team may monitor your anticoagulant therapy more closely and watch you for signs of bleeding, especially in the first few days after adding the NSAID.
- Report bruising, nosebleeds, red or dark urine or stool, or bleeding that won't stop.
- Tell any provider before spinal or epidural procedures, since this combination raises the risk of a spinal blood collection.
- Ask your pharmacist whether an alternative pain reliever or added stomach protection makes sense for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Apixaban and Valdecoxib together?
Taking Eliquis (apixaban) with valdecoxib adds up to a higher bleeding risk, so keep both as prescribed but watch closely for bleeding and check with your pharmacist or doctor about whether a safer pain option fits you. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Valdecoxib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Valdecoxib interaction managed?
If your care team has you on both, keep taking them as prescribed unless they tell you otherwise. The main goal here is closer monitoring and awareness. Your team may monitor your anticoagulant therapy more closely and watch you for signs of bleeding, especially in the first few days after adding the NSAID. Report bruising, nosebleeds, red or dark urine or stool, or bleeding that won't stop. Tell… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Valdecoxib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: Dynastat intravenous injection, intramuscular injection, parecoxib sodium intravenous injection, intramuscular injection. Pfizer Australia Pty Ltd (per Australian Register of Therapeutic Goods), West Ryde, Australia, 2017. DailyMed
- Product Information: PRADAXA(R) oral capsules, dabigatran etexilate mesylate oral capsules. Boehringer Ingelheim Pharmaceuticals (per manufacturer), Ridgefield, CT, 2015. DailyMed
- Product Information: SAVAYSA(TM) oral tablets, edoxaban oral tablets. Daiichi Sankyo, Inc. (per FDA), Parsippany, NJ, 2015. DailyMed
Keep reading about Apixaban
Keep reading about Valdecoxib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist